Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice
- PMID: 16280127
- DOI: 10.1016/j.atherosclerosis.2005.10.004
Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice
Abstract
Polyunsaturated fatty acids (PUFA) are thought to influence plasma lipid levels, atherosclerosis, and the immune system. In this study, we fed male LDL receptor deficient (LDLR(-/-)) mice and immune incompetent LDLR(-/-) RAG2(-/-) mice diets containing predominantly saturated fats (milk fat) or PUFA (safflower oil) to determine if the response to diet was influenced by immune status. Relative to milk fat diet, plasma lipid and VLDL levels in both the LDLR(-/-) and LDLR(-/-) RAG2(-/-) mice fed safflower oil diet were lower, suggesting that the primary effect of PUFA on plasma lipids was not due to its inhibition of the immune system. Neither diet nor immune status influenced hepatic triglyceride production and post-heparin lipase activity, suggesting that the differences in triglyceride levels are due to differences in rates of catabolism of triglyceride-rich lipoproteins. While both diets promoted atherogenesis, both aortic root and innominate artery atherosclerosis in LDLR(-/-) mice was less in safflower oil fed animals. In contrast, a site-specific effect of PUFA was observed in the immune incompetent LDLR(-/-) RAG2(-/-). In these mice, aortic root atherosclerosis, but not innominate artery atherosclerosis, was less in PUFA fed animal. These results suggest that PUFA and the immune system may influence innominate artery atherosclerosis by some overlapping mechanisms.
Similar articles
-
The effects of N-6 polyunsaturated fatty acid supplementation on the lipid composition and atherogenesis in mouse models of atherosclerosis.Atherosclerosis. 2000 Jun;150(2):285-93. doi: 10.1016/s0021-9150(99)00377-9. Atherosclerosis. 2000. PMID: 10856520
-
Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.Atherosclerosis. 2014 Jan;232(1):40-51. doi: 10.1016/j.atherosclerosis.2013.10.016. Epub 2013 Oct 31. Atherosclerosis. 2014. PMID: 24401215
-
Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.Circ Res. 2012 Sep 28;111(8):982-90. doi: 10.1161/CIRCRESAHA.112.267468. Epub 2012 Aug 7. Circ Res. 2012. PMID: 22872154
-
Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis.Curr Opin Lipidol. 2019 Feb;30(1):1-9. doi: 10.1097/MOL.0000000000000565. Curr Opin Lipidol. 2019. PMID: 30586346 Review.
-
The immune system and murine atherosclerosis.Curr Drug Targets. 2007 Dec;8(12):1297-306. doi: 10.2174/138945007783220669. Curr Drug Targets. 2007. PMID: 18220706 Review.
Cited by
-
Paradoxical effect of a pequi oil-rich diet on the development of atherosclerosis: balance between antioxidant and hyperlipidemic properties.Braz J Med Biol Res. 2012 Jul;45(7):601-9. doi: 10.1590/s0100-879x2012007500074. Epub 2012 May 10. Braz J Med Biol Res. 2012. PMID: 22570088 Free PMC article.
-
VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.J Lipid Res. 2009 Mar;50(3):376-385. doi: 10.1194/jlr.M800284-JLR200. Epub 2008 Oct 28. J Lipid Res. 2009. PMID: 18957695 Free PMC article.
-
T Cells in Atherosclerosis in Ldlr-/- and Apoe-/- Mice.J Immunol Sci. 2018;2(3):69-76. doi: 10.29245/2578-3009/2018/3.1144. Epub 2018 Jun 27. J Immunol Sci. 2018. PMID: 30854522 Free PMC article.
-
Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice.Drug Des Devel Ther. 2015 Sep 10;9:5203-11. doi: 10.2147/DDDT.S86969. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26392754 Free PMC article.
-
Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis.Circulation. 2011 Dec 20;124(25):2933-43. doi: 10.1161/CIRCULATIONAHA.111.034850. Epub 2011 Nov 21. Circulation. 2011. PMID: 22104546 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical